oppalerts.com →
IVF Reproductive Medicine

Oncofertility Patient

Knowledge Graph Entities
Dominant · SE Outbound Links ρ=0.492

AI recommendation signal analysis across 338 domains for the Oncofertility Patient persona in IVF Reproductive Medicine.

338Domains Tracked
4.3MReddit Posts
5,598Wikipedia Articles
674KOpen Web Matches
Oncofertility Patient_persona.report
EntityScore
Prelude Fertility
68.9
Pacific Fertility Center Los Angeles (PFCLA)
68.9
Mayo Clinic
60.0
Human Rights Campaign
60.0
Frontiers in Energy Efficiency
60.0
Want a custom AI visibility audit for IVF Reproductive Medicine?

This report tracks how AI models and search engines recommend companies across 100 industries. If you want the same analysis run specifically against your own site and competitors, get in touch.

Get in touch
About This Report

How to use this page

Persona view: this page is scoped to this persona's queries alone.
Use Case

Check your knowledge-graph footprint

Wikidata is the structured knowledge graph behind Wikipedia, search engines, and many AI systems. If the graph does not know a brand, machines have less to anchor an answer on. See which entities carry this segment's topics and brands, and whether its top domains have an entity at all.

How It's Calculated

Where the numbers come from

We scan every Wikidata entity record (labels, descriptions, property values) for this segment's topic phrases and brand hostnames. Entity records are short structured data, so counts run far smaller than article text. Coverage checks which entities claim each domain as an official website.

Overview

What's on this page

Top-entity charts, the full entity table, and a knowledge-graph coverage check for this segment's most LLM-recommended domains.

Segment Totals

Knowledge graph at a glance

How much of the Wikidata knowledge graph touches Oncofertility Patient. Entity records are short structured data (labels, descriptions, property values), so these counts run far smaller than Wikipedia article text; what matters is which entities show up, not raw volume.

18K
Entities With Topic Matches
1,333
Entities Mentioning Brands
18K
Topic Phrase Matches
1,446
Brand Mentions
Top Domains

Knowledge graph coverage

Whether a Wikidata entity claims each of this segment's most LLM-recommended domains as its official website. A brand without an entity is invisible to systems that navigate the web through the knowledge graph.

7 of 25 top domains for Oncofertility Patient have a knowledge-graph entity.

DomainKnowledge Graph EntityWikidata ID
fertilitypreservation.orgNot in the knowledge graph-
allianceforfertilitypreservation.orgNot in the knowledge graph-
livestrong.orgLivestrong FoundationQ196066
fertilehope.orgNot in the knowledge graph-
shadygrovefertility.comShady Grove Fertility CenterQ30281964
myoncofertility.orgNot in the knowledge graph-
savemyfertility.orgNot in the knowledge graph-
ccrmivf.comColorado Center for Reproductive MedicineQ30281877
resolve.orgNot in the knowledge graph-
oncofertility.msu.eduNot in the knowledge graph-
asrm.orgAmerican Society for Reproductive MedicineQ466817
reproductivefacts.orgNot in the knowledge graph-
sart.orgNot in the knowledge graph-
rmanetwork.comNot in the knowledge graph-
oncofertility.northwestern.eduNot in the knowledge graph-
fertilepreservation.orgNot in the knowledge graph-
reprotech.comNot in the knowledge graph-
extendfertility.comNot in the knowledge graph-
fertilitywithinreach.orgNot in the knowledge graph-
nyulangone.orgNYU Langone HealthQ6956114
bostonivf.comBoston IVFQ30269486
ccrmfertility.comNot in the knowledge graph-
mskcc.orgHarold E. VarmusQ295691
fertilityscout.orgNot in the knowledge graph-
fertilityhopeeurope.orgNot in the knowledge graph-
Wikidata

Top knowledge-graph entities

The entity records where Oncofertility Patient's brands and topics appear. Brand Mentions is the more reliable single ranking here; broadly used phrases can surface large unrelated entities in the topic view. Blended merges the two on a log scale (brand mentions weighted higher, 0 to 100). Bars and entity names link to the record; entities with no label show their Wikidata ID. The table follows the selected view.


EntityBlendedBrand MentionsTopic Matches
Prelude Fertility68.931
Pacific Fertility Center Los Angeles (PFCLA)68.931
Mayo Clinic60.040
Human Rights Campaign60.040
Frontiers in Energy Efficiency60.040
Colorado Center for Reproductive Medicine58.221
Sher Fertility58.221
Pacific Fertility Center51.730
Challenges and strategies in building a foundational digital health data integration ecosystem: a systematic review and thematic synthesis51.730
Clinical trial NCT0759738251.730
Clinical trial NCT0758582551.730
Clinical trial NCT0757161651.730
Clinical trial NCT0757162951.730
Clinical trial NCT0761103251.730
American Society for Reproductive Medicine43.111
Reproductive Medicine Associates of New York43.111
Reproductive Medicine Associates of New Jersey43.111
Massachusetts General Hospital41.020
Nucleic Acids Research41.020
Q22988341.020
National Cancer Institute41.020
Ferring Pharmaceuticals41.020
The University of Texas MD Anderson Cancer Center41.020
Frontiers in Neuroanatomy41.020
Frontiers in Cellular Neuroscience41.020
Frontiers in Pharmacology41.020
Frontiers in Psychology41.020
Rusk Institute of Rehabilitation Medicine41.020
Cleveland Clinic41.020
American Family Physician41.020
American Journal of Translational Research41.020
Biomedical Optics Express41.020
Carilion Clinic41.020
ClinicalTrials.gov41.020
dbSNP41.020
Henry Ford Health41.020
H. Lee Moffitt Cancer Center & Research Institute41.020
Northwell Health41.020
Western Journal of Medicine41.020
Trends in Amplification41.020
Ulster Medical Journal41.020
The AAPS Journal41.020
Rice41.020
AAPS PharmSciTech41.020
International Journal of Mental Health Systems41.020
Journal of Urban Health41.020
Neural Development41.020
Journal of the Society of Laparoendoscopic Surgeons41.020
Frontiers in Systems Neuroscience41.020
Frontiers in Energy Research41.020
UCLA Health System41.020
Q2064174241.020
NewYork-Presbyterian Westchester41.020
Frontiers in Bioengineering and Biotechnology41.020
Oregon Graduate Center41.020
The Journal of clinical and aesthetic dermatology41.020
Alcohol research : current reviews41.020
American Society of Clinical Oncology educational book / ASCO41.020
Dermato-endocrinology41.020
British Heart Journal41.020
The western journal of emergency medicine41.020
Psychiatry41.020
Mycobiology41.020
Frontiers in Psychiatry41.020
Frontiers in Endocrinology41.020
Frontiers in Plant Science41.020
Frontiers in Cell and Developmental Biology41.020
Frontiers in Ecology and Evolution41.020
Frontiers in physics41.020
San Diego Fertility Center41.020
Carilion Roanoke Community Hospital41.020
Shady Grove Fertility Center41.020
Fertility Centers of Illinois41.020
New Hope Fertility Center41.020
Syosset Hospital41.020
Johns Hopkins Medicine41.020
Advanced Optical Technologies41.020
University of Utah Health Care41.020
Oncology Issues41.020
Christopher R. Conley41.020
Frontiers in Genome Editing41.020
Frontiers in Neurogenesis41.020
Frontiers in Conservation Science41.020
University of Pennsylvania Division of Endocrinology, Diabetes and Metabolism41.020
Stanford Children's Health41.020
Frontiers in Bioinformatics41.020
Frontiers in Health Services41.020
Progyny, Inc.41.020
Frontiers in High Performance Computing41.020
Frontiers in Sustainable Resource Management41.020
Frontiers in Arachnid Science41.020
Frontiers in RNA Research41.020
Frontiers in Fish Science41.020
Frontiers in Malaria41.020
Frontiers in Bacteriology41.020
Frontiers in Organizational Psychology41.020
Frontiers in Epigenetics and Epigenomics41.020
Frontiers in Medical Engineering41.020
Frontiers in Mammal Science41.020
Frontiers in Sustainable Energy Policy41.020
Frontiers in Network Physiology41.020
Ovarian tissue and oocyte cryopreservation40.004
Ovarian tissue and oocyte cryopreservation40.004
assisted reproductive technology34.503
fertility clinic34.503
Fertility and Sterility34.503
Ovarian tissue and oocyte cryopreservation34.503
A global perspective on assisted reproductive technology fertility treatment: an 8-country fertility specialist survey34.503
Blastocyst culture and transfer in clinical-assisted reproduction34.503
Fertility-Preserving Treatment Options in Patients with Malignant Hematological Diseases34.503
Emergency IVF versus ovarian tissue cryopreservation: decision making in fertility preservation for female cancer patients34.503
Blastocyst culture and transfer in clinical-assisted reproduction: a committee opinion34.503
Xenotransplantation of cryopreserved human ovarian tissue—a systematic review of MII oocyte maturation and discussion of it as a realistic option for restoring fertility after cancer treatment34.503
Fertility Preservation Options for Men and Women With Cancer34.503
Mature oocyte cryopreservation: a guideline34.503
Effect of embryo freezing on perinatal outcome after assisted reproduction techniques: lessons from the Latin American Registry of Assisted Reproduction34.503
Prevalence and Predictors of Sperm Banking in Adolescents Newly Diagnosed With Cancer: Examination of Adolescent, Parent, and Provider Factors Influencing Fertility Preservation Outcomes34.503
Fertility preservation for men with testicular cancer: Is sperm cryopreservation cost effective in the era of assisted reproductive technology?34.503
Live birth following in vitro maturation of oocytes retrieved from extracorporeal ovarian tissue aspiration and embryo cryopreservation for 5 years34.503
What is the quality of information on social oocyte cryopreservation provided by websites of Society for Assisted Reproductive Technology member fertility clinics?34.503
Essential elements of informed consent for elective oocyte cryopreservation: a Practice Committee opinion34.503
Update on fertility preservation from the Barcelona International Society for Fertility Preservation–ESHRE–ASRM 2015 expert meeting: indications, results and future perspectives†‡34.503
Re: Fertility Preservation for Men with Testicular Cancer: Is Sperm Cryopreservation Cost Effective in the Era of Assisted Reproductive Technology?34.503
Egg Freezing Pilot Study34.503
Blastocyst culture and transfer in clinical-assisted reproduction34.503
Assessment of United States fertility clinic websites according to the American Society for Reproductive Medicine (ASRM)/Society for Assisted Reproductive Technology (SART) guidelines34.503
Female fertility preservation: feasibility of emergency IVF for embryo freezing34.503
Blastocyst culture and transfer in clinically assisted reproduction: a committee opinion34.503
Ovarian tissue cryopreservation for fertility preservation in 418 girls and adolescents up to 15 years of age facing highly gonadotoxic treatment. Twenty years of experience at a single center34.503
6. Ovarian Tissue Cryopreservation Is a Feasible and Safe Procedure in a Pediatric, Adolescent and Young Adult Population for Fertility Preservation Prior to Gonadotoxic Treatment34.503
GYN-FIV a.s.34.503
Vitrification (ovocytes)27.302
Journal of Assisted Reproduction and Genetics27.302
Reproductive Medicine and Biology27.302
Tamoxifen or letrozole versus standard methods for women with estrogen-receptor positive breast cancer undergoing oocyte or embryo cryopreservation in assisted reproduction27.302
Tamoxifen or letrozole versus standard methods for women with estrogen-receptor positive breast cancer undergoing oocyte or embryo cryopreservation in assisted reproduction27.302
Current achievements and future research directions in ovarian tissue culture, in vitro follicle development and transplantation: implications for fertility preservation27.302
Journal of Experimental & Clinical Assisted Reproduction: shaping the future of research and practice in reproductive endocrinology/infertility27.302
Fertility preservation during cancer treatment: clinical guidelines27.302
Surgical Aspects of Ovarian Tissue Removal and Ovarian Tissue Transplantation for Fertility Preservation27.302
Ovarian tissue transport to expand access to fertility preservation: from animals to clinical practice27.302
Impact of men's dairy intake on assisted reproductive technology outcomes among couples attending a fertility clinic27.302
Fertility Preservation after a Cancer Diagnosis: A Systematic Review of Adolescents', Parents', and Providers' Perspectives, Experiences, and Preferences27.302
Risk of major congenital anomalies after assisted hatching: analysis of three-year data from the national assisted reproduction registry in Japan27.302
The role of assisted hatching in in vitro fertilization: a review of the literature. A committee opinion27.302
Pregnancy outcomes after assisted reproductive technology27.302
The status of assisted reproductive technology in Korea in 201227.302
Commentary. Cancer diagnosis - the role of urgent referral guidelines27.302
Analysis of oocyte cryopreservation in assisted reproduction: the Italian National Register data from 2005 to 200727.302
Fertility preservation among the cancer patients by ovarian tissue cryopreservation, transplantation, and follicular development27.302
How the FMR1 gene became relevant to female fertility and reproductive medicine27.302
Fertility preservation outcomes may differ by cancer diagnosis27.302
Fertility preservation for girls and young women with cancer: population-based validation of criteria for ovarian tissue cryopreservation27.302
Oocyte cryopreservation: a feasible fertility preservation option for reproductive age cancer survivors.27.302
Ovarian tissue cryopreservation followed by controlled ovarian stimulation and pick-up of mature oocytes does not impair the number or quality of retrieved oocytes27.302
Oocyte cryopreservation and ovarian tissue banking27.302
Breast cancer in young women: special considerations in multidisciplinary care27.302
Sperm banking and assisted reproduction treatment for couples following cancer treatment of the male partner27.302
Emergency IVF for embryo freezing to preserve female fertility: a French multicentre cohort study.27.302
Factors influencing pregnancy rates with a combined clomiphene citrate/gonadotropin protocol for non-assisted reproductive technology fertility treatment27.302
Oocyte Cryopreservation for Fertility Preservation in Postpubertal Female Children at Risk for Premature Ovarian Failure Due to Accelerated Follicle Loss in Turner Syndrome or Cancer Treatments27.302
Fertility Preservation in Reproductive Age Women with Cancer27.302
Access to fertility treatment by gays, lesbians, and unmarried persons: a committee opinion27.302
Risk of breast cancer following fertility treatment—A registry based cohort study of parous women in Norway27.302
Pronuclear embryo cryopreservation experience: outcomes for reducing the risk of ovarian hyperstimulation syndrome and for fertility preservation in cancer patients27.302
A healthy delivery of twins by assisted reproduction followed by preimplantation genetic screening in a woman with X-linked dominant incontinentia pigmenti27.302
Fertility treatment when the prognosis is very poor or futile27.302
Access to fertility treatment by gays, lesbians, and unmarried persons27.302
Effect of Antifreeze Protein on Mouse Ovarian Tissue Cryopreservation and Transplantation27.302
Semen Analysis in Cancer Patients Referred for Sperm Cryopreservation before Chemotherapy over a 15-Year Period in Korea27.302
Cryopreservation time does not decrease follicular viability in ovarian tissue frozen for fertility preservation27.302
Combined strategy for fertility preservation in an oncologic patient: vitrification of in vitro matured oocytes and ovarian tissue freezing27.302
Ovarian tissue banking for cancer patients: fertility preservation, not just ovarian cryopreservation27.302
Optimal timing for elective egg freezing27.302
What is the most relevant standard of success in assisted reproduction?: challenges in measuring and reporting success rates for assisted reproductive technology treatments: what is optimal?27.302
Human oocyte cryopreservation: a valid alternative to embryo cryopreservation?27.302
Oncologists' use of patient educational materials about cancer and fertility preservation27.302
Utilization rates and results of long-term embryo cryopreservation before gonadotoxic treatment27.302
Oocyte versus embryo cryopreservation for fertility preservation in cancer patients: guaranteeing a women's autonomy27.302
Ovarian tissue cryopreservation for fertility preservation in cancer patients: successful establishment and feasibility of a multidisciplinary collaboration27.302
The beneficial effects of polyethylene glycol-superoxide dismutase on ovarian tissue culture and transplantation27.302
Oncofertility: a grand collaboration between reproductive medicine and oncology27.302
Reasons Why Young Women Accept or Decline Fertility Preservation After Cancer Diagnosis27.302
Genetic considerations related to intracytoplasmic sperm injection (ICSI).27.302
Guidelines for reducing the risk of viral transmission during fertility treatment27.302
Round spermatid nucleus injection (ROSNI).27.302
The role of fertility preservation in patients with endometriosis27.302
Cancer and fertility preservation: fertility preservation in breast cancer patients27.302
Implications of sperm banking for health-related quality of life up to 1 year after cancer diagnosis27.302
Current status of assisted reproductive technology in Korea, 201127.302
Cryopreservation/transplantation of ovarian tissue and in vitro maturation of follicles and oocytes: challenges for fertility preservation27.302
Use of letrozole in assisted reproduction: a systematic review and meta-analysis.27.302
Preimplantation genetic testing: a Practice Committee opinion27.302
Techniques for ovarian tissue, whole ovary, oocyte and embryo cryopreservation27.302
Fertility preservation: successful transplantation of cryopreserved ovarian tissue in a young patient previously treated for Hodgkin's disease.27.302
An evaluation of embryo, zygote and oocyte cryopreservation in assisted reproductive technology27.302
Breast cancer and fertility preservation27.302
Cancer and fertility preservation in Puerto Rico: a qualitative study of healthcare provider perceptions27.302
Assisted reproduction and fertility preservation techniques in cancer patients27.302
Fertility preservation in cancer patients using stored ovarian tissue: clinical aspects27.302
Optimizing natural fertility27.302
Fertility preservation in males with cancer: 16-year monocentric experience of sperm banking and post-thaw reproductive outcomes27.302
Cryopreservation and autotransplantation of human ovarian tissue prior to cytotoxic therapy--a technique in its infancy but already successful in fertility preservation27.302
Ovarian tissue cryopreservation and transplantation among alternatives for fertility preservation in the Nordic countries - compilation of 20 years of multicenter experience27.302
Fertility Preservation Options after Gonadotoxic Chemotherapy27.302
Breast cancer and fertility preservation27.302
Current approach to fertility preservation by embryo cryopreservation27.302
Random start or emergency IVF/in vitro maturation: a new rapid approach to fertility preservation27.302
Laparoscopic ovarian tissue harvesting for cryopreservation: an effective and safe procedure for fertility preservation27.302
The promise of in vitro maturation in assisted reproduction and fertility preservation.27.302
Fertility preservation in girls and adolescents before chemotherapy and radiation - review of the literature27.302
Oocyte cryopreservation as a fertility preservation measure for cancer patients27.302
Elective single-embryo transfer27.302
Cryopreservation of ovarian tissue for fertility preservation in young female oncological patients27.302
Ovarian tissue and follicle transplantation as an option for fertility preservation27.302
Intracytoplasmic sperm injection (ICSI) for non-male factor infertility: a committee opinion27.302
Cancer and fertility preservation: Barcelona consensus meeting27.302
In vitro maturation: a committee opinion27.302
The wobbly evidence base of reproductive medicine27.302
Misconduct in third-party assisted reproduction: a committee opinion27.302
Ovarian tissue cryopreservation: a committee opinion27.302
Role of assisted hatching in in vitro fertilization: a guideline27.302
Recommended practices for the management of embryology, andrology, and endocrinology laboratories: a committee opinion27.302
Does weight loss in overweight or obese women improve fertility treatment outcomes? A systematic review27.302
Autotransplantation of cryopreserved ovarian tissue--effective method of fertility preservation in cancer patients.27.302
Fertility preservation in the female cancer patient27.302
Who should be offered sperm banking for fertility preservation? A survey of UK oncologists and haematologists.27.302
Role of tubal surgery in the era of assisted reproductive technology: a committee opinion27.302
Successful Pregnancy and Neobladder Subsequent to Muscle Invasive Bladder Cancer and Fertility Preserving Surgery: Case Report and Review of the Literature27.302
Role of the mental health professional in education and support of the medical staff27.302
Subclinical hypothyroidism in the infertile female population: a guideline27.302
Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy27.302
Sperm cryopreservation and assisted reproductive technology outcome in patients with spinal cord injury.27.302
Fertility preservation in pre-pubertal girls with cancer: the role of ovarian tissue cryopreservation.27.302
Fertility preservation in Turner syndrome27.302
Ovarian Tissue Cryopreservation for Benign Gynecologic Disease: A Case of Ovarian Torsion and Review of the Literature27.302
Correct coding for laboratory procedures during assisted reproductive technology cycles27.302
Chapter 16 Directional Freezing of Ovarian Tissue and Freeze-Drying of Stem Cells for Fertility Preservation27.302
A nationwide UK survey of female fertility preservation prior to cancer treatment27.302
Maternal Racial and Ethnic Disparities in Neonatal Birth Outcomes With and Without Assisted Reproduction27.302
Mature Oocyte Cryopreservation for Fertility Preservation27.302
Female fertility preservation strategies: cryopreservation and ovarian tissue in vitro culture, current state of the art and future perspectives27.302
Ewe Ovarian Tissue Vitrification: A Model for the Study of Fertility Preservation in Women.27.302
Ninety-five orthotopic transplantations in 74 women of ovarian tissue after cytotoxic treatment in a fertility preservation network: tissue activity, pregnancy and delivery rates27.302
Embryo transfer techniques: an American Society for Reproductive Medicine survey of current Society for Assisted Reproductive Technology practices27.302
Guidance on the limits to the number of embryos to transfer: a committee opinion27.302
Emergent Oocyte Cryopreservation with a Novel Ovarian Transposition Technique in a Colorectal Cancer Patient: A Combined Approach for Fertility Preservation. A Case Report27.302
The Past, Present and Future of Fertility Preservation in Cancer Patients27.302
Oocyte cryopreservation for fertility preservation in women with cancer27.302
Sperm Banking: Fertility Preservation for Male Patients With Cancer27.302
Successful fertility preservation following ovarian tissue vitrification in patients with primary ovarian insufficiency27.302
The role of sperm banking in fertility preservation27.302
Cryopreservation of ovarian tissue for fertility preservation in a large cohort of young girls: focus on pubertal development27.302
Ovarian Tissue Collection for Cryopreservation in Pediatric Age: Laparoscopic Technical Tips27.302
Fertility preservation and reproduction in patients facing gonadotoxic therapies: a committee opinion27.302
Sperm banking for fertility preservation: a 20-year experience27.302
Factors affecting decision making about fertility preservation after cancer diagnosis: a qualitative study27.302
In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation.27.302
Assisted reproductive techniques in Latin America: the Latin American Registry, 201327.302
Assisted reproductive medicine in Poland --Fertility and Sterility Special Interest Group of the Polish Gynaecological Society (SPiN PTG) 2012 report27.302
Position statement on West Nile virus: a committee opinion27.302
Patient-physician communication barriers regarding fertility preservation among newly diagnosed cancer patients27.302
Letrozole for ovulation induction and fertility preservation by embryo cryopreservation in young women with endometrial carcinoma27.302
Recommendations for practices utilizing gestational carriers: a committee opinion27.302
American Society for Reproductive Medicine/Society for Assisted Reproductive Technology position statement on West Nile virus27.302
Fertility preservation and reproduction in cancer patients27.302
American Society for Reproductive Medicine/Society for Assisted Reproductive Technology position statement on West Nile virus27.302
Risk of ectopic pregnancy is linked to endometrial thickness in a retrospective cohort study of 8120 assisted reproduction technology cycles27.302
American Society for Reproductive Medicine/Society for Assisted Reproductive Technology position statement on West Nile Virus27.302
Ethical issues in fertility preservation for adolescent cancer survivors: oocyte and ovarian tissue cryopreservation27.302
Microsurgical vasoepididymostomy with sperm cryopreservation for future assisted reproduction27.302
Position on reproductive donors and smallpox vaccine: a committee opinion27.302
Current differences and consequences of legislation on practice of assisted reproductive technology in the Nordic countries. The Nordic Committee on Assisted Reproduction of the Scandinavian Federation of Societies of Obstetrics and Gynecology27.302
Impact of single embryo transfer policy on perinatal outcomes in fresh and frozen cycles—analysis of the Japanese Assisted Reproduction Technology registry between 2007 and 201227.302
Safety in reproductive medicine: breadth, depth and discovery27.302
Embryo Cryopreservation Following In-Vitro Maturation for Fertility Preservation in a Woman with Mullerian Adenosarcoma: A Case Report27.302
Fertility preservation for trans men: frozen-thawed in vitro matured oocytes collected at the time of ovarian tissue processing exhibit normal meiotic spindles27.302
Fertility preservation in women of the childbearing age: Indications and strategies27.302
Cryopreservation ofin vitromatured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy27.302
Fertility preservation in breast cancer patients: the state of art in 2014?27.302
The Russian experience of autotransplantation of vitrified ovarian tissue to a cancer patient27.302
Effect of necrostatin on mouse ovarian cryopreservation and transplantation27.302
Optimal vitrification protocol for mouse ovarian tissue cryopreservation: effect of cryoprotective agents and in vitro culture on vitrified-warmed ovarian tissue survival27.302
Restoring fertility with frozen ovarian tissue; experimental results27.302
Fertility preservation by ovarian stimulation and oocyte cryopreservation in a 14-year-old adolescent with Turner syndrome mosaicism and impending premature ovarian failure27.302
Human ovarian tissue preservation: is vitrification acceptable method for assisted reproduction?27.302
Combining ovarian tissue cryobanking with retrieval of immature oocytes followed by in vitro maturation and vitrification: an additional strategy of fertility preservation27.302
Pregnancies and live births after 20 transplantations of cryopreserved ovarian tissue in a single center27.302
Recommendations for development of an emergency plan for in vitro fertilization programs: a committee opinion27.302
Recommendations for development of an emergency plan for in vitro fertilization programs: a committee opinion27.302
Guidelines for development of an emergency plan for in vitro fertilization programs27.302
First French live-birth after oocyte vitrification performed before chemotherapy for fertility preservation27.302
Cancer and fertility preservation: international recommendations from an expert meeting27.302
Oocyte cryopreservation after controlled ovarian hyperstimulation in mosaic Turner syndrome: another fertility preservation option in a dedicated UK clinic27.302
Cryobanking of human ovarian tissue: do women still want their tissue stored beyond 5 years?27.302
Repetitive oocyte donation: a committee opinion27.302
Optimizing natural fertility: a committee opinion27.302
Recommendations for reducing the risk of viral transmission during fertility treatment with the use of autologous gametes: a committee opinion27.302
Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen27.302
Ovarian tissue banking and fertility preservation in cancer patients: histological and immunohistochemical evaluation.27.302
Is there any place for oocyte cryopreservation after cancer treatment?27.302
Embryo transfer by reproductive endocrinology fellows vs attending physicians: are live birth rates comparable?27.302
Evidence-based medicine and the role of the private sector in assisted reproduction: a response to Dr Fishel’s commentary ‘Evidenced-based medicine and the role of the National Health Service in assisted reproduction’27.302
Risk-sharing or refund programs in assisted reproduction: a committee opinion27.302
Optimizing human oocyte cryopreservation for fertility preservation patients: should we mature then freeze or freeze then mature?27.302
Developing a Referral System for Fertility Preservation Among Patients With Newly Diagnosed Cancer27.302
Embryo yield after in vitro fertilization in women undergoing embryo banking for fertility preservation before chemotherapy27.302
Society for Assisted Reproductive Technology position statement on donor suitability of recipients of smallpox vaccine (vaccinia virus).27.302
Society for Assisted Reproductive Technology position statement on donor suitability of recipients of smallpox vaccine (vaccinia virus).27.302
Society for assisted reproductive technology position statement on donor suitability of recipients of smallpox vaccine (vaccinia virus).27.302
Society for assisted reproductive technology position statement on donor suitability of recipients of smallpox vaccine (vaccinia virus).27.302
Is sperm cryopreservation an option for fertility preservation in patients with spinal cord injury-induced anejaculation?27.302
Guidelines on number of embryos transferred27.302
Cryopreservation of ovarian tissue for fertility preservation: no evidence of malignant cell contamination in ovarian tissue from patients with breast cancer27.302
Progesterone supplementation during the luteal phase and in early pregnancy in the treatment of infertility: an educational bulletin27.302
Prognostic indicators of assisted reproduction technology outcomes of cycles with ultralow serum antimüllerian hormone: a multivariate analysis of over 5,000 autologous cycles from the Society for Assisted Reproductive Technology Clinic Outcome Repo27.302
Need for Comprehensive Counseling in Women Requesting Oocyte Cryopreservation27.302
Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation27.302
Evolution of a reproductive endocrinologist: the Society for Reproductive Endocrinology and Infertility fellows retreat and preliminary results of manpower survey27.302
Posthumous assisted reproduction: a survey of attitudes of couples seeking fertility treatment and the degree of agreement between intimate partners27.302
Viral infections among couples for assisted reproduction in a fertility clinic in Nigeria.27.302
Fertility preservation with ovarian stimulation protocols prior to cancer treatment27.302
No increase in autism-associated genetic events in children conceived by assisted reproduction27.302
Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion27.302
Ovarian tissue cryopreservation in young cancer patients for fertility preservation27.302
Medical egg freezing: the importance of a patient-centered approach to fertility preservation27.302
Medical egg freezing and cancer patients' hopes: Fertility preservation at the intersection of life and death27.302
Oocyte Cryopreservation for Fertility Preservation in Healthy Women27.302
Knowledge, attitudes, and intentions toward fertility awareness and oocyte cryopreservation among obstetrics and gynecology resident physicians27.302
Fertility preservation and refreezing of transplanted ovarian tissue-a potential new way of managing patients with low risk of malignant cell recurrence27.302
Provision of fertility services for women at increased risk of complications during fertility treatment or pregnancy: an Ethics Committee opinion27.302
Financial "risk-sharing" or refund programs in assisted reproduction: an Ethics Committee opinion27.302
Parental influences on sperm banking attempts among adolescent males newly diagnosed with cancer27.302
Assisted reproductive technology in the United States: 2001 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology registry27.302
Assisted reproductive technology in the United States: 2000 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry27.302
Assisted reproductive technology in the United States: 1999 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry27.302
Assisted reproductive technology in the United States: 1998 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry27.302
Single-Incision Laparoscopic Surgery for Ovarian Tissue Cryopreservation27.302
Ovarian tissue cryopreservation and retransplantation – what do patients think about it?27.302
A Focus on Maternal Health Before Assisted Reproduction: Results From a Pilot Survey of Canadian IVF Medical Directors27.302
New methods to improve the safety assessment of cryopreserved ovarian tissue for fertility preservation in breast cancer patients27.302
Sperm banking and rate of assisted reproduction treatment: insights from a 15-year cryopreservation program for male cancer patients27.302
Assisted reproductive technology in reproductive medicine - possibilities and limitations27.302
Fertility Preservation Services for Women With Newly Diagnosed Cancer: A National Assessment27.302
Medical and elective fertility preservation: impact of removal of the experimental label from oocyte cryopreservation27.302
Fertility Preservation Before Cancer Treatment: Options, Strategies, and Resources27.302
Fertility Preservation Through Oocyte Cryopreservation in a Patient with Ovarian Dysgerminocarcinoma: A Case Report27.302
Combination of ovarian tissue harvesting and immature oocyte collection for fertility preservation increases preservation yield27.302
Left Out in the Cold: Arguments Against Non-Medical Oocyte Cryopreservation27.302
Transplantation of mouse ovarian tissue: Comparison of the transplantation sites27.302
Fertility preservation in the transgender patient: expanding oncofertility care beyond cancer27.302
Revised minimum standards for practices offering assisted reproductive technologies: a committee opinion27.302
Ovarian Tissue Cryopreservation and Transplantation: A Realistic, Effective Technology for Fertility Preservation27.302
Developmental competence of oocytes isolated from surplus medulla tissue in connection with cryopreservation of ovarian tissue for fertility preservation27.302
Recommendations for gamete and embryo donation: a committee opinion27.302
Fertility preservation using controlled ovarian hyperstimulation and oocyte cryopreservation in a premenarcheal female with myelodysplastic syndrome27.302
Fertility preservation utilizing controlled ovarian hyperstimulation and oocyte cryopreservation in a premenarcheal female with myelodysplastic syndrome27.302
A transportation network for human ovarian tissue is indispensable to success for fertility preservation.27.302
Improving fertility preservation in cancer: ovarian tissue cryobanking followed by ovarian stimulation can be efficiently combined.27.302
2008 Guidelines for gamete and embryo donation: a Practice Committee report27.302
Round spermatid nucleus injection (ROSNI).27.302
Revised minimum standards for practices offering assisted reproductive technologies27.302
Guidelines for development of an emergency plan for in vitro fertilization programs27.302
Oocyte cryopreservation as alternative to embryo cryopreservation - some pertinent ethical concerns27.302
Response to the Human Fertilisation and Embryology Authority's consultation document on research and fertility treatment using human ova and ovarian tissue obtained from live women, cadavers or fetuses27.302
Antimüllerian hormone as a predictor of live birth following assisted reproduction: an analysis of 85,062 fresh and thawed cycles from the Society for Assisted Reproductive Technology Clinic Outcome Reporting System database for 2012-2013.27.302
Evaluation of quantitative polymerase chain reaction markers for the detection of breast cancer cells in ovarian tissue stored for fertility preservation27.302
Costs of medically assisted reproduction treatment at specialized fertility clinics in the Danish public health care system: results from a 5-year follow-up cohort study27.302
Outcomes of transplantations of cryopreserved ovarian tissue to 41 women in Denmark27.302
1995 assisted reproductive technology success rates: national summary and fertility clinic report.27.302
Fertility preservation in children newly diagnosed with cancer: existing standards of practice in Australia and New Zealand.27.302
2006 Guidelines for Gamete and Embryo Donation27.302
Elements to be considered in obtaining informed consent for ART.27.302
Encouraging results despite complexity of multidisciplinary care of HIV-infected women using assisted reproduction techniques27.302
Use of fetal oocytes in assisted reproduction27.302
Efficacy of ovarian tissue cryopreservation for fertility preservation: lessons learned from 545 cases27.302
Optimizing natural fertility: a committee opinion27.302
Minimal residual disease of leukemia and the quality of cryopreserved human ovarian tissue in vitro27.302
Expectations for success in fertility treatment involving assisted reproduction27.302
Limited Value of Ovarian Function Markers following Orthotopic Transplantation of Ovarian Tissue after Gonadotoxic Treatment27.302
Discussing fertility preservation at the time of cancer diagnosis: Dissatisfaction of young females27.302
A comprehensive method for the conservation of mouse strains combining natural breeding, sperm cryopreservation and assisted reproductive technology27.302
Revised guidelines for human embryology and andrology laboratories27.302
AIDA for reproductive medicine and the fertility clinic27.302
Facing a cancer diagnosis: empowering parents to speak with adolescents about sperm banking27.302
AIUM practice guideline for ultrasonography in reproductive medicine27.302
Clinical effects of oocyte cryopreservation in assisted reproduction technology27.302
Ovarian tissue cryopreserved for fertility preservation from patients with Ewing or other sarcomas appear to have no tumour cell contamination27.302
Recommendations for practices utilizing gestational carriers: a committee opinion27.302
Trust women to choose: a response to John a Robertson's 'Egg freezing and Egg banking: empowerment and alienation in assisted reproduction'.27.302
Provider Influences on Sperm Banking Outcomes Among Adolescent Males Newly Diagnosed With Cancer27.302
A national study of the provision of oncology sperm banking services among Canadian fertility clinics27.302
Sperm cryopreservation in adolescents and young adults with cancer: results of the French national sperm banking network (CECOS)27.302
Systematic proposal of fertility preservation by mature oocyte cryopreservation for recurrent benign ovarian tumors27.302
Oocyte/embryo cryopreservation before chemotherapy for breast cancer27.302
Fertility preservation and reproduction in patients facing gonadotoxic therapies: an Ethics Committee opinion27.302
Clinical practice guidelines for fertility preservation in young women undergoing gonadotoxic treatment: an overview and critical appraisal of methodological quality and content27.302
Abstracts for 2018 Foundation for Reproductive Medicine Translational Reproductive Biology and Clinical Reproductive Endocrinology Conference27.302
Position statement on West Nile virus: a committee opinion27.302
Deliveries following fertility preservation by ovarian tissue cryopreservation without autotransplantation-what should be expected?27.302
Planned oocyte cryopreservation for women seeking to preserve future reproductive potential: an Ethics Committee opinion27.302
Misconduct in third-party assisted reproduction: an Ethics Committee opinion27.302
Re: Parental Influences on Sperm Banking Attempts among Adolescent Males Newly Diagnosed with Cancer27.302
Fertility preservation with random-start controlled ovarian stimulation and embryo cryopreservation for early pregnancy-associated breast cancer27.302
Ethical obligations in fertility treatment when intimate partners withhold information from each other: an Ethics Committee opinion27.302
Gender reassignment and assisted reproduction: An ethical analysis. Bristol Centre for Reproductive Medicine Ethics Advisory Committee27.302
Shared-risk or refund programs in assisted reproduction. The Ethics Committee of the American Society for Reproductive Medicine27.302
Egg freezing for fertility preservation and family planning: a nationwide survey of US Obstetrics and Gynecology residents27.302
La cryopréservation ovocytaire va-t-elle relancer l’intérêt du prélèvement chirurgical de spermatozoïdes synchrone du recueil ovocytaire en cas d’azoospermie non obstructive ?27.302
Limited importance of pre-embryo pronuclear morphology (zygote score) in assisted reproduction outcome in the absence of embryo cryopreservation27.302
Prevalence of abnormal semen analysis and levels of adherence with fertility preservation in men undergoing therapy for newly diagnosed cancer: A retrospective study in 2906 patients27.302
Oocyte Cryopreservation27.302
Preserving fertility in women with cancer (PreFer): Decision-making and patient-reported outcomes in women offered egg and embryo freezing prior to cancer treatment27.302
Fertility Preservation With Ovarian Tissue Freezing27.302
Sperm Banking Among Adolescents Newly Diagnosed With Cancer: Development of a Profiling and Referral Tool27.302
Abstracts for 2017 Foundation for Reproductive Medicine Translational Reproductive Biology and Clinical Reproductive Endocrinology Conference27.302
What advice should we give our patients to preserve their fertility and avoid needing oocyte donation in the future? - A Social Fertility Preservation program27.302
Oocyte cryopreservation for future fertility: comparison of ovarian response between cancer and non-cancer patients27.302
Safety data for the use of nasal human menopausal gonadotropins: a potential novel approach for fertility treatment27.302
Ovarian Tissue Cryopreservation for Fertility Preservation27.302
Ovarian Tissue Freezing For Fertility Preservation27.302
Fertility Preservation by Ovarian and Oocyte Cryopreservation27.302
Efficacy and Tolerance of an Ovarian Stimulation Protocol Combining Follicle Stimulating Hormone (FSH) and Degarelix Acetate in Female Candidates for Fertility Preservation Before Chemotherapy for Breast Cancer27.302
Outcome of immature oocytes collection of 119 cancer patients during ovarian tissue harvesting for fertility preservation27.302
Female Fertility Preservation through Stem Cell-based Ovarian Tissue Reconstitution In Vitro and Ovarian Regeneration In Vivo27.302
Ovarian Tissue Freezing For Fertility Preservation In Women Facing A Fertility Threatening Medical Diagnosis/Treatment27.302
Female Fertility Preservation Using Ovarian Tissue Cryopreservation Before Highly Gonadotoxic Cancer Treatment27.302
Newborns From Patients Treated With ART (Assisted Reproductive Technology)27.302
The Experience of TYAC Offered Ovarian Tissue Cryopreservation27.302
Ovarian Tissue Cryopreservation in Children27.302
Sperm banking before chemotherapy or radiotherapy for cancer27.302
Assisted reproductive technology in the United States and Canada: 1994 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry27.302
Assisted reproductive technology in the United States and Canada: 1993 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry27.302
Reproductive medicine and assisted reproduction--present status and perspectives in the Czech Republic27.302
Female fertility preservation before sterilizing treatment: contribution of ovarian tissue cryopreservation27.302
Assisted reproductive technology in the United States: 1997 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry27.302
Sperm cryopreservation in adolescents with newly diagnosed cancer27.302
A rational basis for antiphospholipid antibody testing and selective immunotherapy in assisted reproduction: a rebuttal to the American Society for Reproductive Medicine Practice opinion. American Society for Reproductive Immunology Antiphospholipid27.302
Fertility preservation by ovarian tissue cryopreservation27.302
Round spermatid nucleus injection (ROSNI)27.302
Assisted Reproductive Technology in the United States and Canada: 1995 Results Generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry27.302
Assisted reproductive technology in the United States: 1996 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry27.302
Evaluation of Fertility in Young Adults Who Did or Did Not Store Testicular Tissue Before a Treatment Possibly Leading to Later Fertility Problems.27.302
The role of assisted hatching in in vitro fertilization: a review of the literature. A Committee opinion27.302
Correct coding for laboratory procedures during assisted reproductive technology cycles27.302
Preimplantation genetic diagnosis27.302
Guidelines on number of embryos transferred27.302
Revised guidelines for human embryology and andrology laboratories27.302
Access to fertility treatment by gays, lesbians, and unmarried persons27.302
Revised minimum standards for practices offering assisted reproductive technologies27.302
[Questionnaire survey in Japan for sperm cryopreservation before chemotherapy ]27.302
Ovarian tissue cryopreservation as a perspective for fertility preservation27.302
Correct coding for laboratory procedures during assisted reproductive technology cycles27.302
The relative contribution of assisted reproductive technologies and ovulation induction to multiple births in the United States 5 years after the Society for Assisted Reproductive Technology/American Society for Reproductive Medicine recommendation27.302
Guidelines for advertising by ART programs27.302
Sperm banking before gonadotoxic treatment--11-years experience27.302
Guidelines on the number of embryos transferred27.302
Guidelines for advertising by ART programs27.302
Revised minimum standards for practices offering assisted reproductive technologies27.302
Correct coding for laboratory procedures during assisted reproductive technology cycles27.302
Round spermatid nucleus injection (ROSNI)27.302
Blastocyst production and transfer in clinical assisted reproduction27.302
Shared-risk or refund programs in assisted reproduction27.302
Assisted reproduction in male cancer survivors: fertility treatment and outcome in 67 couples27.302
Fertility treatment when the prognosis is very poor or futile27.302
Adolescents treated for cancer and fertility preservation. Psychological aspects27.302
ACOG Committee Opinion No. 405: ovarian tissue and oocyte cryopreservation27.302
Assisted reproductive technology has been detrimental to academic reproductive endocrinology and infertility27.302
Assisted reproductive technology has been detrimental to academic reproductive endocrinology and infertility: depth of the problem and possible solutions27.302
Professionals' views on the issues and challenges arising from providing a fertility preservation service through sperm banking to teenage males with cancer27.302
Response by the leadership of the Society of Assisted Reproductive Technology (SART) to the article “Assisted Reproduction and Choices in the Biotech Age”27.302
Preimplantation genetic testing: a Practice Committee opinion27.302
Guidelines for reducing the risk of viral transmission during fertility treatment27.302
Genetic considerations related to intracytoplasmic sperm injection (ICSI)27.302
The role of assisted hatching in in vitro fertilization: a review of the literature. A Committee opinion27.302
Correct coding for laboratory procedures during assisted reproductive technology cycles27.302
Revised guidelines for human embryology and andrology laboratories27.302
Young males' experiences of sperm banking following a cancer diagnosis - a qualitative study27.302
Committee opinion: role of tubal surgery in the era of assisted reproductive technology27.302
Testicular sperm cryopreservation for male fertility preservation27.302
Recommendations for practices utilizing gestational carriers: an ASRM Practice Committee guideline27.302
Fertility treatment when the prognosis is very poor or futile: a committee opinion27.302
Results after assisted reproduction at a public fertility clinic27.302
Position statement on West Nile virus: a committee opinion27.302
Correct coding for laboratory procedures during assisted reproductive technology cycles27.302
Sperm banking in adolescent males with nephrotic syndrome: defining the limits of access to fertility preservation27.302
Guidelines on number of embryos transferred27.302
Tumor cell contamination in ovarian tissue cryopreserved before gonadotoxic treatment: should we systematically exclude ovarian autograft in a cancer survivor?27.302
Criteria for number of embryos to transfer: a committee opinion27.302
Possibilities of cryopreservation of ovarian tissue for fertility preservation in cancer patients27.302
Success and challenges in fertility preservation after ovarian tissue grafting27.302
AIUM Practice Guideline for the Performance of a Focused Reproductive Endocrinology and Infertility Scan27.302
Treatment of advanced ovarian carcinoma: surgery before chemotherapy or chemotherapy before surgery?27.302
Cryopreservation and transplantation of ovarian tissue exclusively to postpone menopause: technically possible but endocrinologically doubtful27.302
Fertility preservation in breast cancer patients by embryo cryopreservation after ovarian stimulation with letrozole and FSH27.302
Assessing information and service needs of young adults with cancer at a single institution: the importance of information on cancer diagnosis, fertility preservation, diet, and exercise27.302
Use of reproductive technology for sex selection for nonmedical reasons27.302
Processing of semen by density gradient centrifugation selects spermatozoa with longer telomeres for assisted reproduction techniques27.302
[Assisted Reproductive Technology in Female Transplant Recipients: Experience of a Reproductive Medicine Unit and Literature Review]27.302
Cryoconservation of ovarian tissue: indications and outcome of the patients27.302
The use of preimplantation genetic testing for aneuploidy (PGT-A): a committee opinion27.302
Attitude towards ovarian tissue and oocyte cryopreservation for non-medical reasons: a cross-sectional study27.302
Patient factors associated with sperm cryopreservation among at-risk adolescents newly diagnosed with cancer27.302
Use of exogenous gonadotropins for ovulation induction in anovulatory women: a committee opinion27.302
Reporting assisted reproductive technology success rates on Australian and New Zealand fertility clinic websites27.302
Oncologic oocyte cryopreservation: national comparison of fertility preservation between women with and without cancer27.302
Minimum standards for practices offering assisted reproductive technologies: a committee opinion27.302
Cryopreservation of Ovarian Tissue: Opportunities Beyond Fertility Preservation and a Positive View Into the Future27.302
Assisted Reproductive Technology and the Reproductive Endocrinology and Infertility Specialist in the U.S. Military27.302
Factors associated with successful pregnancy in women of late reproductive age with uterine fibroids who undergo embryo cryopreservation before surgery27.302
Patient non-attendance at urgent referral appointments for suspected cancer and its links to cancer diagnosis and one year mortality: A cohort study of patients referred on the Two Week Wait pathway27.302
Re: Assisted Reproductive Technology Outcomes in Female-to-Male Transgender Patients Compared with Cisgender Patients: A New Frontier in Reproductive Medicine27.302
Androgenicity and fertility treatment in women with unexplained infertility27.302
Ovarian stimulation and assisted reproductive technology outcomes in women transplanted with cryopreserved ovarian tissue: a systematic review27.302
Assisted reproductive technology outcomes in female-to-male transgender patients compared with cisgender patients: a new frontier in reproductive medicine27.302
Assessment of Turkey IVF (In Vitro Fertilization) websites according to the American Society for Reproductive Medicine (ASRM)/Society for Assisted Reproductive Technology (SART) guidelines27.302
Optimizing the opportunity for female fertility preservation in a limited time-frame for patients with cancer using in vitro maturation and ovarian tissue cryopreservation27.302
Recognition and attitudes of Japanese hematologists on sperm banking before chemotherapy: present status from nationwide questionnaire survey27.302
Concept Paper on the Technique of Cryopreservation, Removal and Transplantation of Ovarian Tissue for Fertility Preservation27.302
Laparoscopic ovarian tissue harvesting and orthotopic ovarian cortex grafting for fertility preservation: less is more27.302
[Epithelial ovarian cancer and fertility preservation: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis27.302
Abstracts presented at the 2019 Foundation for Reproductive Medicine Conference on Translational Reproductive Biology and Clinical Reproductive Endocrinology27.302
The ethics of fertility treatment for same-sex male couples: Considerations for a modern fertility clinic27.302
[Medically Assisted Reproduction in Natural Cycle: Outcome Evaluation of a Reproductive Medicine Department]27.302
FERTILITY PRESERVATION: Freezing of ovarian tissue and clinical opportunities27.302
Importance and safety of autologous sperm cryopreservation for fertility preservation in young male patients with cancer27.302
TurnerFertility trial: PROTOCOL for an observational cohort study to describe the efficacy of ovarian tissue cryopreservation for fertility preservation in females with Turner syndrome27.302
Oocyte cryopreservation for fertility preservation in women with ovarian endometriosis27.302
Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion27.302
EUropean REcommendations for female FERtility preservation (EU-REFER): A joint collaboration between oncologists and fertility specialists27.302
Ovarian tissue cryopreservation and transplantation: what advances are necessary for this fertility preservation modality to no longer be considered experimental?27.302
Variation in follicle health and development in cultured cryopreserved ovarian cortical tissue: a study of ovarian tissue from patients undergoing fertility preservation27.302
Fertility treatment when the prognosis is very poor or futile: an Ethics Committee opinion27.302
A Chinese practice guideline of the assisted reproductive technology strategies for women with advanced age27.302
FERTILITY PRESERVATION: Follicle reserve loss in ovarian tissue transplantation27.302
Ovarian tissue cryopreservation for fertility preservation: clinical and research perspectives27.302
Oocyte and ovarian tissue cryopreservation in European countries: statutory background, practice, storage and use27.302
Elective egg freezing and male support: a qualitative study of men's roles in women's fertility preservation27.302
Importance of ovarian tissue cryopreservation in fertility preservation and anti-aging treatment27.302
Cancer and fertility preservation in females: where we stand and where we are heading27.302
Sperm cryopreservation prior to gonadotoxic treatment: experience of a single academic centre over 4 decades27.302
Ovarian tissue health after laparoscopic unilateral oophorectomy: A porcine model for establishing optimized fertility preservation techniques in children27.302
College of American Pathologists and American Society for Reproductive Medicine accreditation of assisted reproductive technology (ART) laboratories is associated with a decrease in take home baby rates of reporting ART laboratories27.302
Erratum to: Relationship between oxidative stress and clinical pregnancy in assisted reproductive technology treatment cycles27.302
Guidelines on the number of embryos transferred27.302
[FERTILITY PRESERVATION BY CRYOPRESERVATION OF TESTICULAR TISSUE FROM PRE-PUBERTAL BOYS UNDERGOING GONADOTOXIC TREATMENT - PRELIMINARY RESULTS]27.302
Success and challenges in fertility preservation after ovarian tissue grafting27.302
[Successful ovarian tissue transplantation in woman with premature ovarian failure after gonadotoxic treatment]27.302
Fertility preservation for children and adolescents before gonadotoxic treatment27.302
Repetitive oocyte donation: a committee opinion27.302
Attitudes and experiences of health care professionals when caring for transgender men undergoing fertility preservation by egg freezing: a qualitative study27.302
Importance of early and precise ascertainment of mosaic Turner syndrome for fertility preservation and assisted reproduction counseling27.302
The quality of information about elective oocyte cryopreservation (EOC) on Australian fertility clinic websites27.302
Evaluation of Reported Fertility Preservation Counseling Before Chemotherapy Using the Quality Oncology Practice Initiative Survey27.302
Intracytoplasmic sperm injection (ICSI) for non-male factor indications: a committee opinion27.302
Cryostorage of reproductive tissues in the in vitro fertilization laboratory: a committee opinion27.302
Fertility preservation in women for medical and social reasons: Oocytes vs ovarian tissue27.302
IVM Survey Among Reproductive Medicine Specialists27.302
Live births following fertility preservation using in-vitro maturation of ovarian tissue oocytes27.302
New insights for fertility preservation by ovarian tissue cryopreservation and transplantation in pediatric cancer patients27.302
How are women supported in making decisions regarding fertility preservation after a breast cancer diagnosis?27.302
Fertility clinic advertising in the United States: is the Society for Assisted Reproductive Technology oversight of advertising policy effective?27.302
Slow-Freezing Cryopreservation Ensures High Ovarian Tissue Quality Followed by In Vivo and In Vitro Methods and Is Safe for Fertility Preservation27.302
Cryopreservation of Oocytes Retrieved from Ovarian Tissue to Optimize Fertility Preservation in Prepubertal Girls and Women27.302
Recommendations for reducing the risk of viral transmission during fertility treatment with the use of autologous gametes: a committee opinion27.302
Fertility Preservation: The Challenge of Freezing and Transplanting Ovarian Tissue27.302
The marketing of elective egg freezing: A content, cost and quality analysis of UK fertility clinic websites27.302
In vitro maturation: a committee opinion27.302
When laparoscopy for fertility preservation prior to gonadotoxic treatment of an anterior mediastinal mass is a dilemma: A case report27.302
“Add-Ons” for Assisted Reproductive Technology: Do Patients Get Honest Information from Fertility Clinics’ Websites?27.302
A modified hydrostatic microfluidic pumpless device for in vitro murine ovarian tissue culture as research model for fertility preservation27.302
Planned oocyte cryopreservation for fertility preservation27.302
Ovarian tissue cryopreservation and transplantation for fertility preservation27.302
A Federated Blockchain Approach for Fertility Preservation and Assisted Reproduction in Smart Cities27.302
Analysis of Fertility Preservation by Ovarian Tissue Cryopreservation in Pediatric Children in China27.302
Fertility Preservation for Adolescent and Young Adult Transmen: A Case Series and Insights on Oocyte Cryopreservation27.302
Optimizing Physical Function Before Cancer Surgery in Older People at Risk27.302
Ovarian Tissue Cryopreservation in Post Pubertal (OTC-Post Pubertal)27.302
Ovarian Tissue Cryopreservation in Pre-Pubertal (OTC-Pre Pubertal)27.302
A retrospective study of ovarian tissue cryopreservation in female patients with hematological diseases for fertility preservation27.302
Oncologic oocyte cryopreservation for fertility preservation: national trends and comparison of cycle characteristics between women with and without cancer27.302
Sperm cryopreservation for fertility preservation in men with non-malignant diseases27.302
Elective egg freezing and male support: a qualitative study of men’s hidden roles in women’s fertility preservation27.302
Sperm cryopreservation for fertility preservation in male patients with cancer at a single-center in Japan27.302
Ovarian tissue cryopreservation: A fertility preservation option for gynecologic oncology patients27.302
Recent Advances in Reproductive Endocrinology: Implications for Fertility Treatment in Gynecology27.302
The challenges of ovarian tissue banking for fertility preservation and restoration27.302
Egg freezing for fertility preservation and family planning: a survey of OB/GYN residents across united states27.302
Fertility preservation decision-making prior to gonadotoxic treatment: an analysis of 451 patients27.302
Ongoing Review of Clinical Outcomes Following Ovarian Tissue Cryopreservation for Fertility Preservation27.302
Fertility preservation methods in women subjected to gonadotoxic treatment or gonadoreducing surgery27.302
Cyprus Fertina IVF Clinic27.302
planned oocyte cryopreservation27.302
Genera PMA27.302
Heinrich Heine25.810
German Wikipedia25.810
Uwe Timm25.810
Georg Ratzinger25.810
Frontiers Media25.810
National Center for Biotechnology Information25.810
Martin Jankowski25.810
Antje Rávic Strubel25.810
Helmut Reichelt25.810
Michael Meister25.810
Martin Suter25.810
Heinz Höhne25.810
Jean Ziegler25.810
University of California, Davis25.810
Arnold Schoenberg25.810
Q18068625.810
Livestrong Foundation25.810
Zeruya Shalev25.810
Maya Hakvoort25.810
Oregon Health and Science University25.810
Harold E. Varmus25.810
Juan Atkins25.810
Phyllis Dillon25.810
Julius Weismann25.810
American Cancer Society25.810
HomoloGene25.810
Nils Schmid25.810
Andrascz Weigoni25.810
Andrea Röpke25.810
Andreas Raselius25.810
Martin Peerson25.810
Carmen Cavallaro25.810
Anna Kaleri25.810
Antje Szillat25.810
Johns Hopkins School of Medicine25.810
Blood25.810
GenBank25.810
Tell Me Why25.810
NewYork–Presbyterian Hospital25.810
Bruno Preisendörfer25.810
University of California, San Francisco25.810
Dana–Farber Cancer Institute25.810
Detlef Opitz25.810
Journal of Virology25.810
Pennsylvania Hospital25.810
Rolf Stolz25.810
Franz H. Mautner25.810
Entrez25.810
Greg Phillinganes25.810
Esther Kinsky25.810
Frank Hammer25.810
Friedel Schuster25.810
Johns Hopkins Hospital25.810
Gerhard Schreiber25.810
Gernot Wolfram25.810
Krixi, Kraxi und die Kroxn25.810
Svealena Kutschke25.810
polymyalgia rheumatica25.810
Lars Rohwer25.810
Memorial Sloan Kettering Cancer Center25.810
Nanoscale Research Letters25.810
eLife25.810
PeerJ25.810
Biophysical Journal25.810
UCLA Ronald Reagan Medical Center25.810
Frontiers in Neuroscience25.810
Journal of Cardiovascular Magnetic Resonance25.810
Mayo Clinic Hospital — Rochester25.810
Simon Pearce25.810
The Dresden Soul Symphony25.810
Till Steffen25.810
Frontiers in Physiology25.810
Frontiers in Genetics25.810
Vattikuti Urology Institute25.810
Cancer Biology and Therapy25.810
Wilfried F. Schoeller25.810
Cancer Imaging25.810
Bioscience Reports25.810
ACS Chemical Neuroscience25.810
Acta Histochemica et Cytochemica25.810
American Society of Clinical Oncology25.810
Aging25.810
Baylor College of Medicine25.810
Brigham and Women's Hospital25.810
GeneReviews25.810
Grossman School of Medicine25.810
Henry Ford Hospital25.810
Biomicrofluidics25.810
Journal of Experimental Medicine25.810
Molecular and Cellular Biology25.810
UC San Diego Health System25.810
Weill Cornell Medicine25.810
Eugene Koonin25.810
GlobalGiving25.810
Department of Health25.810
Johns Hopkins All Children's Hospital25.810
Henry Ford Jackson Hospital25.810
American Academy of Family Physicians25.810
CURE25.810
Canadian Journal of Gastroenterology & Hepatology25.810
Canadian Respiratory Journal25.810
Cancer Information Service25.810
Cancer Treatment Centers of America25.810
Carilion New River Valley Medical Center25.810
Carilion Roanoke Memorial Hospital25.810
Cerebral Cortex25.810
City of Hope National Medical Center25.810
Cn3D25.810
Consensus CDS Project25.810
Conserved Domain Database25.810
CytoJournal25.810
Diabetes Care25.810
Emory Healthcare25.810
Emory University Hospital25.810
Emory University Hospital Midtown25.810
Enid A. Haupt Glass Garden25.810
Eukaryotic Cell25.810
European Journal of Medical Research25.810
Evidence-based Complementary and Alternative Medicine25.810
M Health Fairview25.810
Genetic codes25.810
Geriatric orthopaedic surgery & rehabilitation25.810
Global Health Action25.810
HSS Journal25.810
Harborview Medical Center25.810
Hospital of the University of Pennsylvania25.810
Howard County General Hospital25.810
IBIS25.810
Indian Journal of Nephrology25.810
Indian Journal of Psychological Medicine25.810
International Journal of Clinical and Experimental Medicine25.810
International Journal of Clinical and Experimental Pathology25.810
Journal of Cutaneous and Aesthetic Surgery25.810
Journal of Medical Ethics25.810
Journal of the Experimental Analysis of Behavior25.810
Journal of the International AIDS Society25.810
UCLA Jules Stein Eye Institute25.810
Blood Cancer United25.810
Long Island Jewish Medical Center25.810
Lucile Packard Children's Hospital25.810
Mayo Clinic Hospital – Jacksonville25.810
Mayo School of Health Sciences25.810
McGill Journal of Medicine25.810
Middle East Cancer Consortium25.810
Milbank Quarterly25.810
Molecular Medicine25.810
Morgan Stanley Children's Hospital25.810
NYU Langone Health25.810
National Comprehensive Cancer Network25.810
NewYork-Presbyterian Healthcare System25.810
Lower Manhattan Hospital25.810
Weill Cornell Medical Center25.810
Northwest Hospital & Medical Center25.810
Oregon Health & Science University School of Dentistry25.810
Oregon Health & Science University Hospital25.810
Penn Presbyterian Medical Center25.810
Perelman Center for Advanced Medicine25.810
Psychological Reports25.810
RefSeq25.810
Saint Joseph's Hospital25.810
Scheie Eye Institute25.810
Sexually Transmitted Infections25.810
Sibley Memorial Hospital25.810
Q754108725.810
Stanford Hospital and Clinics25.810
Stanford University Medical Center25.810
The Journal of Chiropractic Education25.810
UCLA Santa Monica Medical Center25.810
UCSF Medical Center25.810
University of Wisconsin Carbone Cancer Center25.810
UniGene25.810
Univec25.810
University Neuropsychiatric Institute25.810
University Orthopaedic Center25.810
University of Chicago Comprehensive Cancer Center25.810
UChicago Medicine25.810
University of Pennsylvania Health System25.810
University of Utah Hospital25.810
University of Washington Medical Center25.810
University of Washington School of Medicine25.810
University of Wisconsin Hospital and Clinics25.810
Victor Velculescu25.810
WWAMI Regional Medical Education Program25.810
Taxonomy database of the U.S. National Center for Biotechnology Information25.810
Sidra Medical and Research Center25.810
Stem Cell Research & Therapy25.810
Johns Hopkins Bayview Medical Center25.810
WikiCon25.810
Theodore H. Schwartz25.810
MMDB25.810
Tissue Barriers25.810
Small GTPases (journal)25.810
The Eugenics Review25.810
Translational Psychiatry25.810
Molecular Autism25.810
Physiological Reports25.810
Cancer Control25.810
Frontiers in Human Neuroscience25.810
Physiotherapy Canada25.810
Clinical and Developmental Immunology25.810
Journal of Nematology25.810
Journal of Physiological Anthropology25.810
The Behavior Analyst25.810
Advances in Pharmacological Sciences25.810
Medical Science Monitor25.810
The World Allergy Organization Journal25.810
Integrative Medicine25.810
Addiction Science and Clinical Practice25.810
Journal of Human Virology25.810
Hong Kong Medical Journal25.810
Molecular Cytogenetics25.810
Organogenesis25.810
Clinical Diabetes25.810
Journal of the American Association for Laboratory Animals25.810
Journal of Children's Orthopaedics25.810
Learning and Memory25.810
Environmental Health Insights25.810
Tobacco Control25.810
American Journal of Tropical Medicine and Hygiene25.810
Genome Integrity25.810
Mobile DNA25.810
Silence: a journal of RNA regulation25.810
Frontiers in Neurology25.810
mBio25.810
Journal of Laboratory Physicians25.810
Frontiers in Integrative Neuroscience25.810
Surgical Neurology International25.810
Frontiers in Computational Neuroscience25.810
Journal of Clinical Imaging Science25.810
Fluids and Barriers of the CNS25.810
Mechthilde Wittmann25.810
Department of Health and Aged Care25.810
Department of Health and Ageing25.810
Department of Health and Family Services25.810
Suburban Hospital25.810
Wikipedia:Lokal K25.810
Gene Expression Omnibus25.810
Margaret Goodell25.810
American Journal of Cancer Research25.810
NCBI Homo sapiens Annotation Release 10625.810
Julian Reichelt25.810
OncoImmunology25.810
NCBI Mus musculus Annotation Release 10425.810
Airlift Northwest25.810
Category:Videos für Wikipedia-Artikel25.810
Felix Gasbarra25.810
Vollum Institute25.810
International Archives of Medicine25.810
Christiane Frohmann25.810
Gerhard Trabert25.810
Q1929525525.810
NCBI Acyrthosiphon pisum Annotation Release 10125.810
NCBI Ailuropoda melanoleuca Annotation Release 10125.810
NCBI Alligator mississippiensis Annotation Release 10025.810
NCBI Anolis carolinensis Annotation Release 10125.810
NCBI Apaloderma vittatum Annotation Release 10025.810
NCBI Apis dorsata Annotation Release 10025.810
NCBI Apis mellifera Annotation Release 10225.810
NCBI Aptenodytes forsteri Annotation Release 10025.810
NCBI Astyanax mexicanus Annotation Release 10025.810
NCBI Bactrocera cucurbitae Annotation Release 10025.810
NCBI Bactrocera dorsalis Annotation Release 10025.810
NCBI Balaenoptera acutorostrata scammoni Annotation Release 10025.810
NCBI Balearica regulorum gibbericeps Annotation Release 10025.810
NCBI Beta vulgaris subsp. vulgaris Annotation Release 10025.810
NCBI Bison bison bison Annotation Release 10025.810
NCBI Bos taurus Annotation Release 10425.810
NCBI Brachypodium distachyon Annotation Release 10125.810
NCBI Brassica rapa Annotation Release 10025.810
NCBI Buceros rhinoceros silvestris Annotation Release 10025.810
NCBI Callithrix jacchus Annotation Release 10225.810
NCBI Callorhinchus milii Annotation Release 10025.810
NCBI Calypte anna Annotation Release 10025.810
NCBI Camelina sativa Annotation Release 10025.810
NCBI Camelus bactrianus Annotation Release 10025.810
NCBI Camelus dromedarius Annotation Release 10025.810
NCBI Camelus ferus Annotation Release 10025.810
NCBI Camponotus floridanus Annotation Release 10025.810
NCBI Caprimulgus carolinensis Annotation Release 10025.810
NCBI Cariama cristata Annotation Release 10025.810
NCBI Chaetura pelagica Annotation Release 10025.810
NCBI Charadrius vociferus Annotation Release 10025.810
NCBI Chelonia mydas Annotation Release 10025.810
NCBI Chlamydotis macqueenii Annotation Release 10025.810
NCBI Chlorocebus sabaeus Annotation Release 10025.810
NCBI Chrysemys picta Annotation Release 10125.810
NCBI Chrysochloris asiatica Annotation Release 10025.810
NCBI Ciona intestinalis Annotation Release 10225.810
NCBI Citrus sinensis Annotation Release 10025.810
NCBI Colius striatus Annotation Release 10025.810
NCBI Corvus brachyrhynchos Annotation Release 10025.810
NCBI Corvus cornix cornix Annotation Release 10025.810
NCBI Cricetulus griseus Annotation Release 10125.810
NCBI Cuculus canorus Annotation Release 10025.810
NCBI Cucumis melo Annotation Release 10025.810
NCBI Cynoglossus semilaevis Annotation Release 10025.810
NCBI Danio rerio Annotation Release 10425.810
NCBI Egretta garzetta Annotation Release 10025.810
NCBI Elaeis guineensis Annotation Release 10025.810
NCBI Elephantulus edwardii Annotation Release 10025.810
NCBI Eptesicus fuscus Annotation Release 10025.810
NCBI Equus przewalskii Annotation Release 10025.810
NCBI Erinaceus europaeus Annotation Release 10025.810
NCBI Esox lucius Annotation Release 10025.810
NCBI Eucalyptus grandis Annotation Release 10025.810
NCBI Eurypyga helias Annotation Release 10025.810
NCBI Felis catus Annotation Release 10125.810
NCBI Felis catus Annotation Release 10225.810
NCBI Fopius arisanus Annotation Release 10025.810
NCBI Fukomys damarensis Annotation Release 10025.810
NCBI Fulmarus glacialis Annotation Release 10025.810
NCBI Gavia stellata Annotation Release 10025.810
NCBI Glycine max Annotation Release 10125.810
NCBI Haliaeetus albicilla Annotation Release 10025.810
NCBI Haliaeetus leucocephalus Annotation Release 10025.810
NCBI Harpegnathos saltator Annotation Release 10025.810
NCBI Larimichthys crocea Annotation Release 10025.810
NCBI Lepisosteus oculatus Annotation Release 10025.810
NCBI Leptonychotes weddellii Annotation Release 10025.810
NCBI Leptosomus discolor Annotation Release 10025.810
NCBI Lipotes vexillifer Annotation Release 10025.810
NCBI Loxodonta africana Annotation Release 10125.810
NCBI Malus domestica Annotation Release 10025.810
NCBI Manacus vitellinus Annotation Release 10025.810
NCBI Meleagris gallopavo Annotation Release 10125.810
NCBI Merops nubicus Annotation Release 10025.810
NCBI Mesitornis unicolor Annotation Release 10025.810
NCBI Microplitis demolitor Annotation Release 10025.810
NCBI Monodelphis domestica Annotation Release 10225.810
NCBI Musa acuminata Annotation Release 10025.810
NCBI Musca domestica Annotation Release 10125.810
NCBI Myotis davidii Annotation Release 10025.810
NCBI Nannospalax galili Annotation Release 10025.810
NCBI Nasonia vitripennis Annotation Release 10125.810
Catherine, Princess of Wales17.201
Systems Biology in Reproductive Medicine17.201
Robert Edwards17.201
Max Mosley17.201
in vitro fertilization17.201
ASA physical status classification system17.201
Lemmy17.201
reproductive medicine17.201
Q45792317.201
Hank Green17.201
egg donation17.201
Tissue bank17.201
Mark Souder17.201
Jason Collins17.201
theranostics17.201
preoperative care17.201
embryo cryopreservation17.201
Creighton Model FertilityCare System17.201
Andy Kershaw17.201
A. A. Gill17.201
Andrew Watson17.201
Assisted zona hatching17.201
Autologous endometrial coculture17.201
Center for Reproductive Medicine17.201
Endocrinology of reproduction17.201
Ericsson method17.201
fertility preservation17.201
fertility tourism17.201
diagnosis of lung cancer17.201
Human Fertilisation and Embryology (Deceased Fathers) Act 200317.201
Template:Assisted reproductive technology17.201
ovarian tissue cryopreservation17.201
poppy seed test17.201
religious response to assisted reproductive technology17.201
Reproductive endocrinology17.201
reproductive surgery17.201
semen collection17.201
Slovenian fertility treatment referendum, 200117.201
Special Program of Assisted Reproduction17.201
third-party reproduction17.201
veterinary oncology17.201
Category:A-Class reproductive medicine articles17.201
Category:Assisted reproductive technology17.201
Category:B-Class reproductive medicine articles17.201
Category:C-Class reproductive medicine articles17.201
Category:FA-Class reproductive medicine articles17.201
Category:FL-Class reproductive medicine articles17.201
Category:GA-Class reproductive medicine articles17.201
Category:High-importance reproductive medicine articles17.201
Category:Low-importance reproductive medicine articles17.201
Category:Mid-importance reproductive medicine articles17.201
Category:Reproductive medicine articles by importance17.201
Category:Reproductive medicine articles by quality17.201
Category:Reproductive medicine task force17.201
Category:Reproductive medicine task force articles17.201
Category:NA-Class reproductive medicine pages17.201
Category:NA-importance reproductive medicine pages17.201
Category:Start-Class reproductive medicine articles17.201
Category:Stub-Class reproductive medicine articles17.201
Category:Top-importance reproductive medicine articles17.201
Category:Unassessed reproductive medicine articles17.201
Category:Unknown-importance reproductive medicine articles17.201
Category:List-Class reproductive medicine articles17.201
Seminars in Reproductive Medicine17.201
Molecular Human Reproduction17.201
Journal of Reproductive Medicine17.201
Obstetrics, Gynaecology and Reproductive Medicine17.201
Anna Glasier17.201
medical assistance to procreation in France17.201
Partner-assisted reproduction17.201
reproductive endocrinology and infertility17.201
cystadenofibroma17.201